| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.23 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |